By Chelsea Naso ( November 19, 2013, 4:31 PM EST) -- Horizon Pharma Inc. said Tuesday that it would buy the U.S. rights to make and sell AstraZeneca PLC's Vimovo for $35 million up front, less than a month after the pharmaceutical giant accused four companies of infringing its patent for the arthritis medication....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.